These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5972513)

  • 21. Hormonal influences on phosphatase activity of rat accessory sexual glands.
    Bialy G; Pincus G
    Endocrinology; 1967 Nov; 81(5):1125-31. PubMed ID: 6052941
    [No Abstract]   [Full Text] [Related]  

  • 22. The antiandrogenic and sebaceous gland inhibitory activity of 6-alpha,6-beta-ethylene 17-alpha-methyl-B-nortestosterone.
    Saunders HL; Ebling FJ
    J Invest Dermatol; 1969 Feb; 52(2):163-8. PubMed ID: 5774895
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on eosinophil granulocytes. IV. Male accessory sex organs of the rat.
    Baker AP; Bergman F; Josefsson B; Paul KG
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):221-4. PubMed ID: 6072688
    [No Abstract]   [Full Text] [Related]  

  • 24. Anabolic-androgenic activity of A-ring modified androstane derivatives. I. A comparison of parenteral activity.
    Nutting EF; Klimstra PD; Counsell RE
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):627-34. PubMed ID: 6012541
    [No Abstract]   [Full Text] [Related]  

  • 25. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether (10361-S), a new orally active anabolic-androgenic steroid.
    Miyake T; Uchida K; Kakushi H; Nomura Y; Kadowaki M
    Jpn J Pharmacol; 1974 Aug; 24(4):551-8. PubMed ID: 4455965
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of megestrol on oestradiol induced growth of the prostatic lobes and the seminal vesicles in castrated rats.
    Salander H; Tisell LE
    Acta Endocrinol (Copenh); 1976 May; 82(1):213-24. PubMed ID: 946712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of steroids with anti-androgenic properties on the androgenic and myotrophic activity of testosterone and its various derivatives].
    Ivanenko TI
    Probl Endokrinol (Mosk); 1978; 24(4):86-91. PubMed ID: 683979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiandrogenic activity of a series of des-A-steroid derivatives.
    Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C
    J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietic activity and androgenic implications of 29 testosterone derivatives in orchiectomized rats.
    Molinari PF; Rosenkrantz H
    J Lab Clin Med; 1971 Sep; 78(3):399-410. PubMed ID: 5092861
    [No Abstract]   [Full Text] [Related]  

  • 30. Proliferative response of rat accessory sex organs to dietary sex hormones after castration or initial dietary administration of estrogen.
    Shirai T; Ikawa E; Imaida K; Tagawa Y; Ito N
    J Urol; 1987 Jul; 138(1):216-8. PubMed ID: 3599213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans-4-hydroxy-3-methoxycinnamic acid (ferulic acid) inhibits the effect of androgens on the rat prostate.
    Saito T; Nohno T; Yoshida H; Yokoya H
    Experientia; 1979 May; 35(5):696-9. PubMed ID: 446686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A singularly long-acting ether of testosterone.
    Saunders FJ
    Proc Soc Exp Biol Med; 1966 Nov; 123(2):303-4. PubMed ID: 5951069
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiment on the biochemical mechanism of action of testosterone].
    Llopis-Cartagena M; Arias-Paciencia M; Sopena Dasi M
    Actas Urol Esp; 1979; 3(3):149-52. PubMed ID: 474257
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of Clematis fusca preparations on androgen target organs].
    Moiseeva RK
    Biull Eksp Biol Med; 1975 Jul; 80(7):60-1. PubMed ID: 1227651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF; Calhoun DW
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of an androgenic-anabolic nonsteroid.
    Zanati G; Wolff ME
    J Med Chem; 1973 Jan; 16(1):90-1. PubMed ID: 4118299
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiandrogen implanted in brain stimulates male reproductive system.
    Bloch GJ; Davidson JM
    Science; 1967 Feb; 155(3762):593-5. PubMed ID: 6015879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of C19 (androstene or androstane) steroids on serum gonadotrophin concentrations and on accessory reproductive organ weights in gonadectomized, adult male rats.
    Verjans HL; Eik-Nes KB
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):829-41. PubMed ID: 576766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANABOLIC AND OTHER HORMONAL ACTIVITIES OF 2-ALPHA, 17-ALPHA-DIMETHYL-19-NORTESTOSTERONE AND ITS DERIVATIVES.
    NAKAMURA K; MASUDA M; FUJIMOTO K
    Jpn J Pharmacol; 1964 Jun; 14():138-49. PubMed ID: 14215542
    [No Abstract]   [Full Text] [Related]  

  • 40. A new antiandrogen, 6alpha-bromo-17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androstan-3-one.
    Boris A; Uskoković M
    Experientia; 1970 Jan; 26(1):9-10. PubMed ID: 5412314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.